PMID- 31715341 OWN - NLM STAT- MEDLINE DCOM- 20200505 LR - 20200505 IS - 1873-3476 (Electronic) IS - 0378-5173 (Linking) VI - 572 DP - 2019 Dec 15 TI - Metronidazole/Hydroxypropyl-beta-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system. PG - 118828 LID - S0378-5173(19)30873-7 [pii] LID - 10.1016/j.ijpharm.2019.118828 [doi] AB - In this study, Metronidazole/Hydroxypropyl-beta-Cyclodextrin (HP-beta-CyD) inclusion complex nanofibrous webs were produced via electrospinning for the purpose of fast-dissolving oral drug delivery. The Metronidazole/HP-beta-CyD inclusion complex aqueous solutions having two different molar ratio of Metronidazole/HP-beta-CyD (1/1 and 1/2) were prepared by using very high concentration of HP-beta-CyD (200%, w/v) in order to achieve polymer-free electrospinning of Metronidazole/HP-beta-CyD nanofibers (NF). Metronidazole was totally encapsulated and preserved without any loss during the electrospinning process in which both systems yielded Metronidazole/HP-beta-CyD NF having the same initial molar ratio of 1/1 and 1/2. The electrospinning of both Metronidazole/HP-beta-CyD (1/1 and 1/2) aqueous solutions yielded uniform and bead-less fiber morphology having ~190 nm average fiber diameter. Both Metronidazole/HP-beta-CyD NF (1/1 and 1/2) samples were in the form of nanofibrous webs with free-standing and flexible character. The structural and thermal characterizations of Metronidazole/HP-beta-CyD NF (1/1 and 1/2) proved that Metronidazole was in the inclusion complex state with HP-beta-CyD in these nanofibrous webs. Metronidazole is an antibiotic which is poorly water-soluble drug, but the phase solubility and dissolution tests revealed that the water-solubility of Metronidazole was significantly enhanced by HP-beta-CyD inclusion complexation. In addition, Metronidazole/HP-beta-CyD (1/1 and 1/2) nanofibrous webs have shown very fast-dissolving behavior when placed in water or contacted to artificial saliva suggesting that such Metronidazole/HP-beta-CyD nanofibrous webs can be suitable for fast-dissolving oral drug delivery. CI - Copyright (c) 2019 Elsevier B.V. All rights reserved. FAU - Celebioglu, Asli AU - Celebioglu A AD - Department of Fiber Science & Apparel Design, College of Human Ecology, Cornell University, Ithaca, NY 14853, United States. Electronic address: ac2873@cornell.edu. FAU - Uyar, Tamer AU - Uyar T AD - Department of Fiber Science & Apparel Design, College of Human Ecology, Cornell University, Ithaca, NY 14853, United States. Electronic address: tu46@cornell.edu. LA - eng PT - Journal Article DEP - 20191109 PL - Netherlands TA - Int J Pharm JT - International journal of pharmaceutics JID - 7804127 RN - 0 (Anti-Bacterial Agents) RN - 0 (Drug Carriers) RN - 059QF0KO0R (Water) RN - 140QMO216E (Metronidazole) RN - 1I96OHX6EK (2-Hydroxypropyl-beta-cyclodextrin) SB - IM MH - 2-Hydroxypropyl-beta-cyclodextrin/*chemistry MH - Administration, Oral MH - Anti-Bacterial Agents/administration & dosage/chemistry MH - Chemistry, Pharmaceutical MH - Drug Carriers/chemistry MH - *Drug Delivery Systems MH - Drug Liberation MH - Metronidazole/*administration & dosage/chemistry MH - *Nanofibers MH - Particle Size MH - Saliva/metabolism MH - Solubility MH - Water/chemistry OTO - NOTNLM OT - Electrospinning OT - Fast-dissolving OT - Hydroxypropyl-beta-cyclodextrin OT - Metronidazole OT - Nanofibers OT - Oral drug delivery EDAT- 2019/11/13 06:00 MHDA- 2020/05/06 06:00 CRDT- 2019/11/13 06:00 PHST- 2019/08/14 00:00 [received] PHST- 2019/10/21 00:00 [revised] PHST- 2019/10/26 00:00 [accepted] PHST- 2019/11/13 06:00 [pubmed] PHST- 2020/05/06 06:00 [medline] PHST- 2019/11/13 06:00 [entrez] AID - S0378-5173(19)30873-7 [pii] AID - 10.1016/j.ijpharm.2019.118828 [doi] PST - ppublish SO - Int J Pharm. 2019 Dec 15;572:118828. doi: 10.1016/j.ijpharm.2019.118828. Epub 2019 Nov 9.